Mercer Global Advisors Inc Nektar Therapeutics Transaction History

Mercer Global Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.51 - $1.05 $8,697 - $17,906	17,054 New	17,054 $10,000
Q3 2019 Nov 12, 2019	SELL	$16.91 - $36.27 $99,853 - $214,174	-5,905 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$31.0 - $36.3 $5,487 - $6,425	-177 Reduced 2.91%	5,905 $210,000
Q1 2019 Apr 23, 2019	BUY	$31.58 - $46.35 $192,069 - $281,900	6,082 New	6,082 $204,000

147

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $201M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.